A recent study in the U.S. has found that estrogen creams, commonly used to alleviate menopause symptoms, are not only safe for older women diagnosed with breast cancer, but may also correlate with increased survival rates.
The research, which was presented at the ASCO meeting, indicated that postmenopausal breast cancer survivors who used hormone creams experienced a reduced risk of disease progression, recurrence, or death. These findings challenge previous concerns that the creams could stimulate the growth of breast cancer cells that rely on hormones.
